Constructing and optimizing 3D atlases from 2D data with application to the developing mouse brain

  1. David M Young
  2. Siavash Fazel Darbandi
  3. Grace Schwartz
  4. Zachary Bonzell
  5. Deniz Yuruk
  6. Mai Nojima
  7. Laurent C Gole
  8. John LR Rubenstein
  9. Weimiao Yu
  10. Stephan J Sanders  Is a corresponding author
  1. University of California, San Francisco, United States
  2. Agency for Science, Technology and Research, Singapore

Abstract

3D imaging data necessitate 3D reference atlases for accurate quantitative interpretation. Existing computational methods to generate 3D atlases from 2D-derived atlases result in extensive artifacts, while manual curation approaches are labor-intensive. We present a computational approach for 3D atlas construction that substantially reduces artifacts by identifying anatomical boundaries in the underlying imaging data and using these to guide 3D transformation. Anatomical boundaries also allow extension of atlases to complete edge regions. Applying these methods to the eight developmental stages in the Allen Developing Mouse Brain Atlas (ADMBA) led to more comprehensive and accurate atlases. We generated imaging data from fifteen whole mouse brains to validate atlas performance and observed qualitative and quantitative improvement (37% greater alignment between atlas and anatomical boundaries). We provide the pipeline as the MagellanMapper software and the eight 3D reconstructed ADMBA atlases. These resources facilitate whole-organ quantitative analysis between samples and across development.

Data availability

The full 3D generated atlases and wild-type brain images are being deposited with the Human Brain Project EBRAINS data platform. All data analyses are included in the manuscript and supporting files.

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. David M Young

    Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Siavash Fazel Darbandi

    Psychiatry, University of California, San Francisco, San Francisco, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Grace Schwartz

    Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Zachary Bonzell

    Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Deniz Yuruk

    Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Mai Nojima

    Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Laurent C Gole

    Institute of Molecular and Cellular Biology, Agency for Science, Technology and Research, Singapore, Singapore
    Competing interests
    The authors declare that no competing interests exist.
  8. John LR Rubenstein

    Department of Psychiatry, University of California, San Francisco, San Francisco, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4414-7667
  9. Weimiao Yu

    Institute of Molecular and Cellular Biology, Agency for Science, Technology and Research, Singapore, Singapore
    Competing interests
    The authors declare that no competing interests exist.
  10. Stephan J Sanders

    Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, United States
    For correspondence
    stephan.sanders@ucsf.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9112-5148

Funding

Brain and Behavior Research Foundation (NARSAD Young Investigator Grant)

  • Stephan J Sanders

National Institute of Mental Health (U01 MH122681)

  • Stephan J Sanders

National Institute of Mental Health (R01 MH109901)

  • Stephan J Sanders

National Institute of Neurological Disorders and Stroke (R01 NS099099)

  • John LR Rubenstein

The authors declare that the funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All procedures and animal care were approved and performed in accordance with institutional guidelines from the University of California San Francisco Laboratory Animal Research Center (LARC). All animal handling complied with the approved Institutional Animal Care and Use Committee (IACUC) protocol (AN180174-02) at the University of California San Francisco.

Copyright

© 2021, Young et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. David M Young
  2. Siavash Fazel Darbandi
  3. Grace Schwartz
  4. Zachary Bonzell
  5. Deniz Yuruk
  6. Mai Nojima
  7. Laurent C Gole
  8. John LR Rubenstein
  9. Weimiao Yu
  10. Stephan J Sanders
(2021)
Constructing and optimizing 3D atlases from 2D data with application to the developing mouse brain
eLife 10:e61408.
https://doi.org/10.7554/eLife.61408

Share this article

https://doi.org/10.7554/eLife.61408

Further reading

    1. Computational and Systems Biology
    Huiyong Cheng, Dawson Miller ... Qiuying Chen
    Research Article

    Mass spectrometry imaging (MSI) is a powerful technology used to define the spatial distribution and relative abundance of metabolites across tissue cryosections. While software packages exist for pixel-by-pixel individual metabolite and limited target pairs of ratio imaging, the research community lacks an easy computing and application tool that images any metabolite abundance ratio pairs. Importantly, recognition of correlated metabolite pairs may contribute to the discovery of unanticipated molecules in shared metabolic pathways. Here, we describe the development and implementation of an untargeted R package workflow for pixel-by-pixel ratio imaging of all metabolites detected in an MSI experiment. Considering untargeted MSI studies of murine brain and embryogenesis, we demonstrate that ratio imaging minimizes systematic data variation introduced by sample handling, markedly enhances spatial image contrast, and reveals previously unrecognized metabotype-distinct tissue regions. Furthermore, ratio imaging facilitates identification of novel regional biomarkers and provides anatomical information regarding spatial distribution of metabolite-linked biochemical pathways. The algorithm described herein is applicable to any MSI dataset containing spatial information for metabolites, peptides or proteins, offering a potent hypothesis generation tool to enhance knowledge obtained from current spatial metabolite profiling technologies.

    1. Computational and Systems Biology
    2. Microbiology and Infectious Disease
    Ruihan Dong, Rongrong Liu ... Cheng Zhu
    Research Article

    Antimicrobial peptides (AMPs) are attractive candidates to combat antibiotic resistance for their capability to target biomembranes and restrict a wide range of pathogens. It is a daunting challenge to discover novel AMPs due to their sparse distributions in a vast peptide universe, especially for peptides that demonstrate potencies for both bacterial membranes and viral envelopes. Here, we establish a de novo AMP design framework by bridging a deep generative module and a graph-encoding activity regressor. The generative module learns hidden ‘grammars’ of AMP features and produces candidates sequentially pass antimicrobial predictor and antiviral classifiers. We discovered 16 bifunctional AMPs and experimentally validated their abilities to inhibit a spectrum of pathogens in vitro and in animal models. Notably, P076 is a highly potent bactericide with the minimal inhibitory concentration of 0.21 μM against multidrug-resistant Acinetobacter baumannii, while P002 broadly inhibits five enveloped viruses. Our study provides feasible means to uncover the sequences that simultaneously encode antimicrobial and antiviral activities, thus bolstering the function spectra of AMPs to combat a wide range of drug-resistant infections.